Yellin Alon, Refaely Yael, Paley Michael, Simansky David
Department of Thoracic Surgery, Sheba Medical Center, Tel Hashomer, Israel.
J Thorac Cardiovasc Surg. 2003 Mar;125(3):554-8. doi: 10.1067/mtc.2003.31.
This study was undertaken to determine the incidence and outcome of major bleeding complicating deep sternal infection after cardiac surgery, to identify predisposing factors and means of prevention, and to clarify management options.
This was a retrospective study of 10,863 consecutive patients, of whom 213 (2.18%) acquired deep sternal infection. With 43 additional referrals, the total number of patients with deep sternal infection was 280. Deep sternal infection was managed by a two-stage scheme. Major bleeding was considered to be bleeding that occurred during or after operation for deep sternal infection from the heart, great vessels, or grafts, or bleeding requiring urgent exploration.
Fifteen patients (5.36%) had major bleeding. The incidences of deep sternal infection and bleeding were highest among patients undergoing coronary artery bypass grafting. Thirteen patients had underlying diseases (type 2 diabetes in 9 cases). Deep sternal infection was diagnosed a median of 15 days after reoperation. Bleeding originated from the right ventricle in 9 patients. In 4 patients bleeding was iatrogenic during surgery for wire removal (n = 2) or reconstruction (n = 2). In 11 it occurred 15 minutes to 15 days (median 2 days) after wire removal, as a result of shearing forces in 7 cases and of infection only in 4 cases. Three patients died immediately. The other 12 were operated on, 6 with complete cardiopulmonary bypass, 2 with femoral cannulation, and 4 without cardiopulmonary bypass. The immediate mortality was 26.7%; the overall mortality was 53.3%. The median length of hospitalization of surviving patients was 38 days.
The probability of development of major bleeding in patients with deep sternal infection was unrelated to the primary operation. The mortality associated with this complication was high. Meticulous technique during wire removal may decrease the risk of major bleeding. The impacts of cardiopulmonary bypass and of the technique and timing of sternal reconstruction remain undetermined.
本研究旨在确定心脏手术后并发深部胸骨感染的大出血发生率及转归,识别易患因素和预防方法,并阐明处理方案。
这是一项对10863例连续患者的回顾性研究,其中213例(2.18%)发生深部胸骨感染。另有43例转诊患者,深部胸骨感染患者总数为280例。深部胸骨感染采用两阶段方案处理。大出血定义为深部胸骨感染手术期间或术后发生的来自心脏、大血管或移植物的出血,或需要紧急探查的出血。
15例患者(5.36%)发生大出血。深部胸骨感染和出血发生率在接受冠状动脉旁路移植术的患者中最高。13例患者有基础疾病(9例为2型糖尿病)。深部胸骨感染在再次手术后中位15天被诊断。9例患者出血源自右心室。4例患者出血是在取钢丝(2例)或重建手术(2例)时医源性造成的。11例出血发生在取钢丝后15分钟至15天(中位2天),7例是由于剪切力,4例仅是由于感染。3例患者立即死亡。其他12例接受了手术,6例采用完全体外循环,2例采用股动脉插管,4例未采用体外循环。即刻死亡率为26.7%;总死亡率为53.3%。存活患者的中位住院时间为